The Manitowoc Company, Inc.
NYSE:MTWAgricultural - Machinery
+$0.58 today
- Market cap
- $801.94M
- Beta
- 1.75
- P/E (TTM)
- 63.2
- EPS (TTM)
- $0.21
Volume 0.28M
Average 0.23M
MTW Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
The Manitowoc Company, Inc.NYSE: MTW
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables turns positive
Q1 FY2026 accounts receivables was $15.8M, compared with -$3.6M a year earlier. Trailing-twelve-month accounts receivables was $10.3M. Over 3 fiscal years it compounded at -37.0% a year.
Context
- Accounts receivables amounted to 0.4% of revenue in FY2025, unchanged from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near $15.8M or moves back toward the trailing-twelve-month quarterly average of $2.58M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (9.1M) USD
- Year-over-year change
- -201.1%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (9.1M) | -201.1% |
| FY2024 | 2024-12-31 | 9M | +196.8% |
| FY2023 | 2023-12-31 | (9.3M) | +74.5% |
| FY2022 | 2022-12-31 | (36.4M) | -766.7% |
| FY2021 | 2021-12-31 | (4.2M) | — |
Accounts Receivables vs competitors
How MTW compares with its peers on the latest reported figures
- MTW's LTM Mar 2026 accounts receivables of $10.3M is the 4th largest of the 10 companies compared; the peer median is $3.61M.
- Its year-over-year change of -53.8% is the 5th highest of 10, against a peer median of -71.8%.
- Accounts receivables amounts to 0.5% of revenue for MTW, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $33.69M | -45.4% | — | 1.1% | |
| LTM Mar 2026 | $19.55M | -0.2% | — | 2.9% | |
| LTM Mar 2026 | $13.1M | -82.8% | — | 0.9% | |
| LTM Mar 2026 | $10.3M | -53.8% | -37.0% | 0.5% | |
| LTM Mar 2026 | $6.68M | -284.5% | — | 1.8% | |
| LTM Mar 2026 | $5.3M | +65.6% | -40.4% | 0.3% | |
| LTM Mar 2026 | $4.8M | +237.1% | -45.2% | 0.3% | |
| LTM Mar 2026 | $3.61M | -71.8% | — | 0.6% | |
| LTM Mar 2026 | $3.28M | -78.6% | — | 0.9% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $727.39K | -230.0% | — | 0.4% |
| Peer median (excluding MTW) | $3.61M | -71.8% | -42.8% | 0.9% | |
Competitors are the stored peer set for MTW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 11M | (123.6M) | 39.2M | 55.8M | 7.2M |
| Depreciation & Amortization | 46.9M | 63.7M | 59.8M | 62.9M | 63M |
| Deferred Income Tax | 600K | (6.6M) | (6M) | (55.6M) | (6.2M) |
| Stock-Based Compensation | 7.1M | 8.5M | 11.5M | 10.9M | 9.5M |
| Change in Working Capital | 3.1M | (35.2M) | (52.1M) | (27.3M) | (52.2M) |
| Accounts Receivables | (4.2M) | (36.4M) | (9.3M) | 9M | (9.1M) |
| Inventory | (68.3M) | (42M) | (46.7M) | 21.4M | (11.6M) |
| Accounts Payables | 62.9M | 40.4M | (28.5M) | (39.1M) | 21.7M |
| Other Working Capital | 12.7M | 2.8M | 32.4M | (18.6M) | (53.2M) |
| Other Non-Cash Items | 7.5M | 170.1M | 10.6M | 2.5M | 900K |
| Operating Cash Flow | 76.2M | 76.9M | 63M | 49.2M | 22.2M |
| Capital Expenditures | (40.4M) | (61.8M) | (77.4M) | (45.7M) | (37.5M) |
| Acquisitions (Net) | (186.2M) | 2.3M | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 300K | 1.5M | 5.6M | 5.3M | (12M) |
| Investing Cash Flow | (226.3M) | (58M) | (71.8M) | (40.4M) | (49.5M) |
| Debt Repayment | 95.1M | (25.1M) | (16.2M) | 27.3M | 60.6M |
| Common Stock Issued | 5.8M | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (3M) | (5.5M) | (5.7M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (1.8M) | 300K | (14.9M) | (5.8M) |
| Financing Cash Flow | 100.9M | (29.9M) | (21.4M) | 6.7M | 54.8M |
| Effect of Forex Changes | (4.1M) | 0 | 200K | (1.9M) | 1.8M |
| Net Change in Cash | (53.3M) | (11M) | (30M) | 13.6M | 29.3M |
| Free Cash Flow | 35.8M | 15.1M | (14.4M) | 3.5M | (15.3M) |
The Manitowoc Company, Inc.
NYSE:MTW
Intrinsic Alpha fair value
Locked
Current Price
$22.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.